Please use this identifier to cite or link to this item: https://doi.org/10.1038/nature10490
Title: Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function
Authors: McDermott-Roe C.
Ye J.
Ahmed R.
Sun X.-M.
Seraf�n A.
Ware J.
Bottolo L.
Muckett P.
Ca�as X.
Zhang J.
Rowe G.C.
Buchan R.
Lu H.
Braithwaite A.
Mancini M.
Hauton D.
Mart� R.
Garc�-Arum� E.
Hubner N.
Jacob H.
Serikawa T.
Zidek V.
Papousek F.
Kolar F.
Cardona M.
Ruiz-Meana M.
Garc�a-Dorado D.
Comella J.X.
Felkin L.E.
Barton P.J.R.
Arany Z.
Pravenec M.
Petretto E.
Sanchis D.
Cook S.A. 
Issue Date: 2011
Publisher: Nature Research
Citation: McDermott-Roe C., Ye J., Ahmed R., Sun X.-M., Seraf�n A., Ware J., Bottolo L., Muckett P., Ca�as X., Zhang J., Rowe G.C., Buchan R., Lu H., Braithwaite A., Mancini M., Hauton D., Mart� R., Garc�-Arum� E., Hubner N., Jacob H., Serikawa T., Zidek V., Papousek F., Kolar F., Cardona M., Ruiz-Meana M., Garc�a-Dorado D., Comella J.X., Felkin L.E., Barton P.J.R., Arany Z., Pravenec M., Petretto E., Sanchis D., Cook S.A. (2011). Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature 478 (7367) : 114-118. ScholarBank@NUS Repository. https://doi.org/10.1038/nature10490
Abstract: Left ventricular mass (LVM) is a highly heritable trait and an independent risk factor for all-cause mortality. So far, genome-wide association studies have not identified the genetic factors that underlie LVM variation, and the regulatory mechanisms for blood-pressure-independent cardiac hypertrophy remain poorly understood. Unbiased systems genetics approaches in the rat now provide a powerful complementary tool to genome-wide association studies, and we applied integrative genomics to dissect a highly replicated, blood-pressure-independent LVM locus on rat chromosome 3p. Here we identified endonuclease G (Endog), which previously was implicated in apoptosis but not hypertrophy, as the gene at the locus, and we found a loss-of-function mutation in Endog that is associated with increased LVM and impaired cardiac function. Inhibition of Endog in cultured cardiomyocytes resulted in an increase in cell size and hypertrophic biomarkers in the absence of pro-hypertrophic stimulation. Genome-wide network analysis unexpectedly implicated ENDOG in fundamental mitochondrial processes that are unrelated to apoptosis. We showed direct regulation of ENDOG by ERR-? and PGC1? (which are master regulators of mitochondrial and cardiac function), interaction of ENDOG with the mitochondrial genome and ENDOG-mediated regulation of mitochondrial mass. At baseline, the Endog-deleted mouse heart had depleted mitochondria, mitochondrial dysfunction and elevated levels of reactive oxygen species, which were associated with enlarged and steatotic cardiomyocytes. Our study has further established the link between mitochondrial dysfunction, reactive oxygen species and heart disease and has uncovered a role for Endog in maladaptive cardiac hypertrophy. � 2011 Macmillan Publishers Limited. All rights reserved.
Source Title: Nature
URI: http://scholarbank.nus.edu.sg/handle/10635/149989
ISSN: 00280836
DOI: 10.1038/nature10490
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

78
checked on Apr 22, 2019

WEB OF SCIENCETM
Citations

80
checked on Dec 19, 2018

Page view(s)

4
checked on Apr 20, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.